Skip to Content
MilliporeSigma
Search Within
Document Type

209-180-7

Applied Filters:
Keyword:'209-180-7'
Showing 1-30 of 56 results for "209-180-7" within Technical Documents
Data Sheet - C6520 - Lot 041K8801
120 140 160 180 200 220 240 260 280 300 0 10000 20000 30000 40000 50000 60000 70000 80000 90000 m/z Abundance 43 55 67 77 91 119 141
Data Sheet - C6520 - Lot 23K8807
120 140 160 180 200 220 240 260 280 300 0 10000 20000 30000 40000 50000 60000 70000 80000 90000 m/z Abundance 41 57 77 91 105 115 128
Data Sheet - C6520 - Lot 41K8801
120 140 160 180 200 220 240 260 280 300 0 10000 20000 30000 40000 50000 60000 70000 80000 90000 m/z Abundance 43 55 67 77 91 119 141
Data Sheet - C6520 - Lot 52K8801
140 160 180 200 220 240 260 280 300 0 50000 100000 150000 200000 250000 300000 350000 400000 450000 m/z Abundance 43 57 77 91 105 119 141 152
Readycult Federal Register Final Rule October 2002
29OCR1 65891Federal Register / Vol. 67, No. 209 / Tuesday, October 29, 2002 / Rules and Regulations March 7, 2002 (67 FR 10532, March 7, 2002). These titles were also on
Montage Albumin Deplete Kit
GERMANY Tel. (06196) 494-0 Fax (06196) 43901 HUNGARY Tel. 01 381 0433 01 381 0434 01 209 3232 Fax 01 209 0295 INDIA Tel. (91) 80-839 46 57 Fax (91) 80-839 63 45 IRELAND Life Sciences and
XP725 Antibody Number-Lot Number 071M4826
250 251 252 273 274 275 276 3.4 205 206 207 208 229 230 231 232 253 254 255 256 277 278 279 280 3.5 209 210 211 212 233 234 235 236 257 258 259 260 281 282 283 284 3.6 213
Impact of Process Loading on Optimization and Scale-Up of TFF Microfiltration
pressure profiles during constant f lux microfiltration of bovine serum albumin. J Membrane Sci, 2002; 209: 363-377. http://dx.doi.org/10.1016/S0376-7388(02)00282-X. [5] Wijmans JG, Nakao S, Smolders CA.
New Research Tools for Signal Transduction and Life Science Research
activities of KDR, Flt-1 and c-Kit (IC50 = 20 nM, 180 nM and 240 nM, respectively), and minimally inhibit c-Src and EGF-R activities (IC50 = 7 µM and 7.� µM). 676481 5 mg $1�4 VEGF Receptor Tyrosine
Product Information - CSAA1
(pT 308) P3862 Signal Transduction P n/d y y 208 PKC α P4334 Signal Transduction P n/d y y 209 PKC β P3203 Signal Transduction P n/d n/d y 210 PKC γ P3328 Signal Transduction
LABORATORY NOTEBOOK ISSUANCE PAGE
61 –64 — 0.58 4.81 245 1.446 Cyclohexane 0.779 80 7 –18 0.98 2.02 200 1.426 Cyclopentane 0.751 50 –94 –37 0.44 1.97 200 1.4 1,2–Dichlorobenzene 1.306 180 –17 65 1.32(25) 9.93(25) 295 1.551 1,2–Dichloroethane
LABORATORY NOTEBOOK ISSUANCE PAGE
61 –64 — 0.58 4.81 245 1.446 Cyclohexane 0.779 80 7 –18 0.98 2.02 200 1.426 Cyclopentane 0.751 50 –94 –37 0.44 1.97 200 1.4 1,2–Dichlorobenzene 1.306 180 –17 65 1.32(25) 9.93(25) 295 1.551 1,2–Dichloroethane
LABORATORY NOTEBOOK ISSUANCE PAGE
61 –64 — 0.58 4.81 245 1.446 Cyclohexane 0.779 80 7 –18 0.98 2.02 200 1.426 Cyclopentane 0.751 50 –94 –37 0.44 1.97 200 1.4 1,2–Dichlorobenzene 1.306 180 –17 65 1.32(25) 9.93(25) 295 1.551 1,2–Dichloroethane
Perfection in every dimension 2014. Inorganic reagents Catalogue
Certipur® 111448 203 Antimony ICP standard traceable to SRM from NIST Sb2O3 in HCl 7 % 1000 mg/l Sb Certipur® 170302 180 Antimony powder for analysis particle size <150 µm EMSURE® 107832 127 Antimony
Outstanding performance Purospher®STAR HPLC and UHPLC columns - EMD
6 5 8 7 10 9 13 12 11 14 16 15 0 0.5 1 1.5 2 2.5 3 3.5 64 min 1 2 3 4 mAU 4.5 5 5.5 40 20 0
PKH Dye Reference Guide
determination of short- and long-term natural killer cell activity. J.Immunol.Methods 1995; 185: 209-216. 77. Kemp RB: Cytotoxicity in an anchorage-independent fibroblast cell line measured by
Brochure: Purospher STAR HPLC and UHPLC Columns
6 5 8 7 10 9 13 12 11 14 16 15 0 0.5 1 1.5 2 2.5 3 3.5 64 min 1 2 3 4 mAU 4.5 5 5.5 40 20 0
QCM Gelatin Invadopodia Assay (Green)
Breast cancer cell movement: imaging invadopodia by TIRF and IRM microscopy. Methods Mol Biol 571: 209-225. 11. Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M, Segall J, Eddy R
WHEATON CELLine CL1000 Tech Paper
0.70 30 4 0.8 20 N RPMI 394 1160 AC.21 G1 180 120 0.70 29 5 0.8 20 N RPMI 402 1608 AC.22 G2b 190 105 0.60 38 6 0.8 20 N RPMI 444 1110 AC.23 G2b
QCM™ Gelatin Invadopodia Assay (Red)
Breast cancer cell movement: imaging invadopodia by TIRF and IRM microscopy. Methods Mol Biol 571: 209-225. 11. Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M, Segall J, Eddy R
Calbiochem Biologics 29.2
Tetrahedron Lett. 39, 7475. US $ 241 241 232 241 232 241 $ 395 $ 245 $ 209 $ 195 To Order Call Customer Service at 800-854-3417
Material Matters Volume 15 number 2 Batteries & Solar Cells
Correa-Baena, J.-P.;. Tress, W. R; Abate, A.; Hagfeldt, A.; Grätzel, M. Science, 2016, 354, 206–209. (7) Jeon, N. J.; Noh, J. H.; Yang, W. S.; Kim, Y. C.; Ryu, S.; Seo, J.; Seok, S. I. Nature 2015
Protocol- 03-0178-00
230 30 # 2 140 4 227 39 # 3 131 4 210 30 # 4 133 3 216 41 # 5 188 4 307 48 # 6 186 3 304 54 # 7 209 3 343 62 # 8
inNovations Newsletter #14
Hradecna, Z., and Szybalski, W. Genomic Research (in press). 7. Grossman, T. H., Kawasaki, E. S., Punreddy, S. R., and Osburne, M. S. (1998) Gene 209, 95–103. 8. Kelley, K. C., Huestis, K. J., Austen, D.
User Guide Equinox SOP Software 2.1 for Windows XP
194 195 198 199 199 199 200 202 202 202 203 203 203 204 204 205 205 206 206 207 207 208 208 209 209 210 210 210 211 211 213 213 213 214 214 215 215 216 216 Contenido Capítulo 4. Exportar
inNovations Newsletter #17
185, 60–89. 2. Grossman, T. W., Kawasaki, E. S., Penreddy, S. R., and Osborne, M. S. (1998) Gene 209, 95–103. 3. Pan, S. and Malcolm, B. A. (2000) BioTechniques 29, 1234–1238. 4. Novy, R. and Morris
XP725 Antibody List Lot 089K4791
705694.2 y n/d n/d 208 Cytokeratin peptide 13 C0791 3860 KRT13 M NP_002265.2 ,NP_705694.2 y n/d n/d 209 Cytokeratin Peptide 17 C9179 3872 KRT17 M NP_000413.1 y n/d y 204 Cytokeratin CK5 C7785 3875 KRT18
XP725 Antibody List Lot 129K4831
705694.2 y n/d n/d 208 Cytokeratin peptide 13 C0791 3860 KRT13 M NP_002265.2 ,NP_705694.2 y n/d n/d 209 Cytokeratin Peptide 17 C9179 3872 KRT17 M NP_000413.1 y n/d y 204 Cytokeratin CK5 C7785 3875 KRT18
XP725 Antibody List Lot 129K4830
705694.2 y n/d n/d 208 Cytokeratin peptide 13 C0791 3860 KRT13 M NP_002265.2 ,NP_705694.2 y n/d n/d 209 Cytokeratin Peptide 17 C9179 3872 KRT17 M NP_000413.1 y n/d y 204 Cytokeratin CK5 C7785 3875 KRT18
Inhibitor Sourcebook 3rd Edition
kinase activities of KDR, Flt-1 and c-Kit (IC50 = 20 nM, 180 nM and 240 nM, respectively), and minimally inhibit c-Src and EGF-R activities (IC50 = 7 µM and 7.3 µM). Further, inactive towards the inhibition
Page 1 of 2